London – 30 October, 2019 – Informa Pharma Intelligence is pleased to announce that The Citeline Awards (previously known as the CARE Awards) is returning for their second year. The awards will once again be held in Boston, MA at the Hyatt Regency, on April 30, 2020.
Following last year’s successful event, which saw companies large and small sharing the spotlight at the awards ceremony in Boston, the Citeline Awards is continuing its mission of recognizing the outstanding contributions of those in Clinical R&D who are improving human lives worldwide through discovery and development of new drugs.
Now in its 5th year, the Citeline Awards spans an array of categories which celebrate excellence among companies, teams, and individuals who are driving innovative change in the pharmaceutical and biomedical industries.
Nominations for the awards are being accepted through January 17 via www.clinicalresearchexcellence.com
Karen Currie, Executive Director, Citeline Editorial said: “Each year we look forward to hosting these awards and to recognizing the exciting, innovative and life-changing work that is being carried out by clinical research professionals in the biopharmaceutical industry. We are pleased to introduce two new award categories for 2020 to acknowledge the growth in adoption of AI in clinical research, and the important role that small biotech companies play in drug development.”
The Citeline Awards focus on honoring the strategic thinkers, risk takers, and innovators who persist in pushing for new breakthroughs in medicine. These remarkable individuals are acknowledged and awarded for their vital work, as they continue to find a cure, extend a life, or alleviate human suffering.
The 2020 Citeline Awards Categories are:
For more information about the 5th Annual Citeline Awards, visit www.clinicalresearchexcellence.com
About Informa Pharma Intelligence
Trusted by over 3,000 of the world’s leading pharmaceutical companies, CROs, med and biotech organizations, and healthcare service providers, the Pharma Intelligence suite of intelligence solutions delivers vital, accurate, and timely intelligence about the drug development pipeline to pharmaceutical and biomedical decision makers around the world.
At Pharma Intelligence, global teams of subject area experts follow and analyze key diseases, clinical trials, drug approvals and R&D activities as part of the breadth and depth of data available to customers. For more information visit pharmaintelligence.informa.com.
Citeline, part of Informa’s Pharma Intelligence vertical, is the world’s most comprehensive source of real-time R&D intelligence for the pharmaceutical industry, featuring an unmatched intelligence collection and enrichment of global clinical trials, clinical trial investigator profiles and drug development pipelines. Citeline is the R&D Intelligence arm of Informa’s Pharma Intelligence vertical, one of the world’s leading providers of drug, device, company, clinical trial and market intelligence in the pharma and medtech markets.